Government of West Bengal
Office of the Deputy Director of Health Services (E&S), WB
Central Medical Stores
141, A J C Bose Road,Kolkata – 700 014
Phone No (033) 2265 4418/4417/4419
E mail : [email protected]
NOTICE INVITING RE E-TENDER FOR PROCUREMENT OF FEW DRUGS, LABORATORY KITS, CHEMICALS &
REAGENTS FOR THE YEAR 2014-2015 BY THE DEPUTY DIRECTOR OF HEALTH SERVICES (E&S), CENTRAL
MEDICAL STORES, KOLKATA-700 014
(Through Pre-qualification)
(Submission of Bid through NIC e tender portal)
NIT No.:-HST/4T-02-2014/DCR-RT/2014-15/020
Dated- 26/12/2014, Kolkata
The Deputy Director of Health Services (E&S) having its office at Central Medical Stores, 141,
Acharya Jagadish Chandra Bose Road, Kolkata – 700 014 is going for Re e-tender on behalf of the Health &
Family Welfare Department, Government of West Bengal for Preparing of Rate Schedule of few drugs, Kits,
Chemicals & Reagents for the year 2014-15, and its extension, if required for a further period of 6 (Six)
months from the Manufacturers/Direct Importers , for supply to Central Medical Stores, decentralized
District Reserve Stores, Medical Colleges & Hospitals, decentralized Hospitals and other Direct Purchasing
Health Units under the Health and Family Welfare Department all over the State of West Bengal. This is in
continuation with this office NIT No HST/1P-02-13/GD/2014-15/003 Dated 20.01.2014
& HST /4T-02-2014/ CR /2014-15/009 Dated, 02.04.2014.
Necessary earnest money to be submitted for participation in the Re Tender through Demand Draft
is Rs. 50,000 per tenderer payable in favour of Dy. Director (Accounts) CMS, WB.
1. GENERAL INSTRUCTIONS:
In the event of e-filing, intending bidder may download the tender documents free of cost from the
website : http://wbtenders.gov.in directly with the help of Digital Signature Certificate or from the
Health & Family Welfare Department’s website www.wbhealth.gov.in & necessary earnest money
may be remitted to the office of the DDHS(E&S) through Demand Draft / Pay Order issued from any
nationalized bank/scheduled bank in India payable at Kolkata drawn in favour of Deputy Director
(Accounts), Central Medical Stores, Kolkata and also to be documented through e-filing.
2. SUBMISSION Of BIDS:
Both Technical bid and Financial Bid are to be submitted concurrently duly digitally signed by the
Company personnel only (having Authorization from the company management) in the website
http:// wbtenders.gov.in. All papers must be submitted in English language with Page Marking.
3. Time Schedules for the Re-tender
THE TIME SCHEDULE FOR OBTAINING THE BID DOCUMENTS, PRE BID MEETINGS, REGISTRATION
WITH THE TENDERING AUTHORITIES, THE SUBMISSION OF BIDS AND OTHER DOCUMENTS ETC. WILL
BE AS PER THE LIST PROVIDED IN CLAUSE NO 30, AS GIVEN BELOW.
4. ELIGIBILITY FOR QUOTING:
Only Manufacturers & Direct Importers of the item/items who are able to supply the assured
quantities as per requirement & have requisite Annual Average Turnover, as per clause no. 5, are
only eligible for quoting. Manufacturers not having the capability to supply the minimum full
assured supply quantity need not apply. Failure of submission of declaration of full assured supply
to the Government of West Bengal will lead to cancellation of tender.
The vendors who were declared L1 but did not execute agreement or did not supply even after
execution of agreement up to 75% of the ordered value as on 30.11.2014 in the previous tender
1
floated by DDHS (E&S), Central Medical Stores or declared black listed by any State Govt. or Govt.
Institutions are not eligible to participate in the current tender.
The Vendors who have been black listed by any Govt. Concern for particular any item(s) need not
quote for that item(s).
5. ANNUAL TURNOVER REQUIREMENTS:
Principal Manufacturer(s)/Importer(s) (inside or outside of West Bengal), State Based PSUs and
State Based Other manufacturing units/CPSU whose average annual Turn Over for last three
financial years is more than Rs. 3 (Three) crore totaling 9 (Nine) crore for the last three years and
S.S.Is, registered in West Bengal whose average annual Turn Over for last three financial years is
more than Rs. 50 (Fifty) lack totalling 1.5 (One & half) crore for the last three years, are only eligible
to participate in the Tender.
6. SUBMISSION OF THE TENDERS:
The tender is to be submitted in a Two Bid System. The approved Bidders of the E-Tender
(Drugs/Kits, Chemicals & Reagents Tender) 2013-14 should have to submit all the technical/financial
documents afresh.
Technical Proposal:
1. “BID A”: Technical Documents:Part I - STATUTORY COVER containing the following documents:
(SINGLE FILE MULTIPLE PAGE SCANNED)
One folder for earnest money deposit with copy of the Demand draft/Pay order should be
uploaded. Local SSI(s) should upload certificate of registration/EM II for claiming EMD exemption.
B
C
D
Copy of Demand Draft of Rs 50,000/- (Fifty Thousand) in favour of Deputy Director
(Accounts), Central Medical Stores submitted to DDHS (E&S) as Earnest Money for the
whole tender.
Certificate of registration/EM II in respect of local SSI
CHECK LIST in the prescribed format
List of items Quoted (to be filled in excel sheet)
E
Application in the prescribed format given in Annexure I
F
Authorization letter of signatory from Company in Annexure II
G
Certification from Chartered Firm about monthly production capacity and 10% sale in the
open market in Annexure III.
H
Copy of agreement between the manufacturer and the Distributor in Annexure IV
I
Declaration from existing CMS approved drug vendors about supply of 75% over ordered
value in Annexure V.
J
ANNEXURE VI as per Draft Affidavit Pro-forma.
A
2
Part I I :-NON-STATUTORY/ MY DOCUMENTS (My Space), Containing the following documents:(a) Company Specific Technical Documents:(SINGLE FILE MULTIPLE PAGE SCANNED)
Sl.
Category
No.
A
Certificates
Sub Category
A1. Certificates
Sub Category Description
PAN Card of the Bidder/Authorized Signatory who
uploads the bid
Professional Tax Registration certificate
ESI Registration certificate
EPF Registration certificate.
Service Tax Registration certificate
VAT/ CST Registration certificate
B.
COMPANY
DETAILS
B1. COMPANY
DETAILS 1
Trade Licence/Enlistment
Current Registration/EM II as local SSI, W.B.
Registration with Registrar of Companies
C.
CREDENTIAL
C1: CREDENTIAL
1
D.
PAYMENT
CERTIFICATE 1
FINANCIAL
INFO
PAYMENT
CERTIFICATE 2
D1. P/L &
BALANCE SHEET
Up-to-date Drug Manufacturing Licence with revised
schedule M & MIII compliance.
Import Licence with validity of IEC Code (for
importers)
List of Purchaser with Credential Certificate from
purchaser( for Importers)
GLP Certificate from the concern Drug Control
Authority with validity
Market Standing Certificate for drug items for the
last 3 years from State Drug Control authority.
No conviction certificate from the concerned state
Drug Control authority for the last three years.
Affidavit About No Conviction From Judicial
Magistrate/Executive Magistrate ( in Annexure VI)
Income Tax Returns submitted for the Assessment
year 2011-12
Income Tax Returns submitted for the Assessment
year 2012-13
Income Tax Returns submitted for the Assessment
year 2013-14
VAT/CST Returns (of the last quarter) for the year
2010-11
VAT/CST Returns (of the last quarter) for the year
2011-12
VAT/CST Returns (of the last quarter) for the year
2012-13
1. P/L & Balance sheet 2010-2011
3. P/L & Balance sheet 2011-2012
3. P/L & Balance sheet 2012-2013
3
(b) Product Specific Technical Documents
(SINGLE FILE MULTIPLE PAGE SCANNED)
Essential Requirements of the Tendering Firm for participation” shall contain all papers related to the
essential requirements of the Tenderer for participation in the tender viz.
A
B
C
D
CLAA with validity & Product approval Documents
Drug Endorsement Certificate/Import Licence in F-10/ Product Approval Certificate for each item
quoted (The items should be marked/highlighted with marker pen mentioning there in the CMS CAT
No. for each particular item).
List of Items imported during the Year 2013-14 ( for Importer)
Market Standing Certificate for last three years from the State Drug Control authority of the
particular products to be quoted in respect of items under drug ( for manufacturer). (The items
should be marked/highlighted with marker pen mentioning there in the CMS CAT No. for each
particular item)
2. “BID B ”: FINANCIAL COVER
BOQ
The folder as “Financial Bid” shall contain:
Base Rate per Accounting Unit inclusive of Entry Tax, Customs Duty (if applicable), Transportation
Charges, Insurance, Delivery Charges, Incidental Charges, Freight Charges, Testing Charges e.t.c. and
exclusive of VAT/CST, Excise duty and Cess (wherever applicable) e.t.c. to be quoted. L1 will be
determined on base price only.
LOAN LICENCE- No drug manufactured under a Loan License shall be offered by a tenderer. But in
case of essential medicines where manufacturer is not marketing the product, loan license will be
allowed subject to the approval of the chairperson of the “TSC”.
7. The tenderers are required to submit the hard copy of Earnest Money Deposit (EMD) in original.
Submission of hard copy of technical bid is not required to be submitted. Submission of hard copy of
Financial Bid is totally prohibited and only be submitted through on line through NIC portal.
8. Evaluation of the tenders:During the tender evaluation process, the “BID A” will be opened first .
Those Bidders who have qualified in respect of the essential & other requirements in “BID A” will be
identified and only their financial bid i. e., “ BID B ” will be opened. The financial bid of those
Tenderer failing to meet the technical & other requirements of participating in the tender will not
be opened and be rejected. The Tenderer offering the item found suitable as per the tender
specifications will only be selected. Final selection of the lowest bidders in respect of Financial Bid is
subject to further verification.
The manufacturing capability of the Tenderer and assured supply capability to the Health & Family
Welfare department, Govt of West Bengal will also be assessed by the DDHS (E&S)/Tender Selection
Committee and the manufacturer capable to supply the assured quantity as per the requirements of
the state to the items for which he has quoted will also be identified and assessed before opening of
financial bid.
The Tenderer who have been so identified to have been technically suitable in the context of above
and are having the manufacturing capability and confirmation about the assured supply
requirements of the state during the tender period and/or have supplied 75% (as on the date of
submission of tender) of the ordered value made to them up to 30th November, 2014 (in respect of
existing vendors) will be deemed to have passed the test of essential and other requirement of the
quoted item or items.
The (Financial Bids) of only these tenderers passing the essential and other requirement test will be
opened then subject to verification of hard copies of the audited balance sheet and Profit & Loss
Accounts of the tenderer for the last three years i.e. for the year 2010-11 , 2011-12 & 2012-13.
4
If found suitable in the context of above pre qualification etc, the Tenderer quoting the lowest rate
will be considered as successful. However, in the event of a particular vendor being L1 for more than
one item, an opportunity of being heard may be given to him about confirmation of assured supply
in respect of items before declaring him L1. Factory inspection may follow for determining
manufacturing capacity and confirmation of assured supply to take final decision in this matter for
determination of L1.
For high volume, vital and life savings item or items, if the H&FW department considers selection or
induction of more vendors for prompt supply for the interest better patient care services or in the
exigency of the situation, counter offers shall be invited from the next higher quoter i.e. L2, L3 and L4
etc to supply at the lowest rate, i.e. at L1 rate. This division of orders shall continue till quoters
assuring of supplying up to 120% of the estimated requirements of the State in respect of the
particular item or items are identified.
THE DECISION OF THE DDHS (E&S)/ TENDER SELECTION COMMITTEE WILL BE FINAL AND BINDING
IN THIS MATTER.
9. APPOINTMENT OF AUTHORISED DISTRIBUTOR:(THE TERMS DISTRIBUTOR IMPLIES AUTHORISED DISTRIBUTOR, C&F AGENT, CSA AGENT, IN
WHATEVER FASHION ADRESSED WHO SHALL FACILITATE THE PROCESS OF TAKING ORDERS,
ENSURING TIMELY SUPPLIES AND COLLECTING PAYMENT ON BEHALF OF THE MANUFACTURERS)
Local SSIs/local PSU/CPSU/local manufacturers are not allowed to engage Distributors for raising bill
and receiving payment in the latter’s favour.
All out of the state manufacturers/ tenderers must have a distributor in this state.
If out-of-state manufacturer proposes that order and payment are to be made in the name of the
Distributor, such Distributor must be an authorized distributor of the Tenderer with average annual
turnover of 50 (Fifty) Lakh i.e. Rs 1.5 (One & Half) Crore for the last three years. The Tenderer shall
submit relevant document to this effect (copy of agreement signed between the tenderer and the
Distributor).If out of state manufacturer proposes that the order & payment are to be made in
favour of the manufacturer & the manufacturer will supply and effect distribution through
authorised C&F, the same is allowed. No annual turnover and agreement is necessary for such
engagement.
In the event of being selected, the hard copies for under mentioned documents along with
‘DISTRIBUTOR SUMMARY’ as per Proforma given herein relating to the Distributor must be
submitted by the tenderer to the DDHS (E&S), before execution of the agreement:
i.
ii.
iii.
iv.
v.
vi.
vii.
Letter of Authority from the Tenderer (manufacturer) in the letter head of the manufacturer duly
signed by the Authorized Signatory of the manufacturer in favour of Distributor stating clearly the
status of the Distributor.
Copy of agreement signed between the tenderer and the Distributor as proof of the Distributor as
the authorized distributor of the manufacturer.
PAN No. & Last year’s Income Tax Return submitted, VAT/ST Registration Certificate & Validity
Documents of the Distributor.
Drugs Licence & its current Renewal Certificate /Validity Certificate, Current Trade Licence.
Current No-conviction certificate from the State Drug Control authority.
Affidavit of non conviction sworn before a Notary/ First Class Judicial Magistrate/Executive
Magistrate.
Average Annual Turnover amounting to Rs. 50 (Fifty) Lakh for the year 2010-11, 2011-12 & 2012-13
totalling Rs. 1.5 (One & Half) Crore for last three years in case the order and payment are to be
made in the name of the Distributor. Copies of annual audited accounts statements for the last
three financial years are required to be submitted as proof.
It is, however, made clear that agreement in pursuance of the accepted tenders will be executed
only with the Tenderer who will be responsible for the supply. In case, the order and payment are to
be made in the name of the Distributor, separate agreement will be executed with such distributor
also. No agreement will, however be executed with the C&F and CSA agent.
5
10. Cost of Earnest Money:a. Each tender has to be submit, unless exempted under the existing orders of the West Bengal
Govt. must deposit Earnest Money in the form of Demand Draft from any Nationalized
Bank/Scheduled bank in India for Rs. 50,000 (Rs Fifty Thousand) only irrespective of the items
quoted.
b. The earnest money is to be deposited in the prescribed time during opening of Bid A. The onus
of providing that a Tenderer is exempted from Earnest Money will lie on the Tenderer and must
be proved by the submission of valid documents.
c. The earnest money of the Tenderer will liable to be forfeited if the Tenderer withdraws his
tender as a whole or for any particular item at any stage after the opening of the tender, or fails
/ refuses to enter into written agreement for any of all of the items of his accepted tender
within the time specified when requested to do so/fails to furnish Performance Bank Guarantee
within the stipulated time.
d. The Earnest Money will be refunded after finalization of the tender or within 3 (three) months
from the date of opening of tender whichever is later against the specific prayer of Tenderer.
e. The Earnest Money will be refunded to the non-qualified bidders in respect of technical bid
against the prayer of the bidder.
11. PREFERENCE & REGULATIONS FOR S.S.I., W.B. & OTHERS AS UNDER NOTED:
Preference will be given to the S.S.I., W.B., P.S.U., W.B. and State Based Other Manufacturers as per
West Bengal Financial Rule incorporated under notification No. 10500-F dated 19.11.04.
Registration as a Small Scale Industries unit after the submission of the tender will not entitle the
Tenderer to get exemption from payment of Earnest Money.
12. DRUGS LICENCE & IMPORT LICENCE:
Certified copy of Drug Licence with current validity certificate along with full list of endorsement
with items highlighted by colouring / underlining of items quoted in the tender must be submitted.
The items should be Marked / Highlighted with marker pen mentioning there in the CMS CAT No. for
each particular items. If the products are not under Drug License, the manufacturer / importer
should submit the product Approval Certificate from the authority concerned.
13. Schedule M III Compliance Certificate/GMP Certificate, GLP certificate & 3 (Three) years Market
Standing Certificate from the Drug Control Authority in respect of drug items. Only manufacturers
having COMPLIANCE OF Revised M & MIII (GMP) & GLP Certificate with three years Market Standing
Certificate of the items to be quoted from the concerned State Drug Control authority (if the
products are under Drug License) are eligible
14. B.I.S. CERTIFICATE:
The item(s) which are under I.S.I. specification must have certificate from Bureau of Indian Standard
and valid endorsement copies.
15. SALES IN THE OPEN MARKET:
The Tenderer must have sales in the open market. At least 10% of the total production of the
material during the last three financial periods should have been sold to any other
organisation/party/persons other than the Health & FW Dept., Govt of West Bengal.
The Tenderer has to submit a declaration certified by a Chartered Accountant regarding total sales
in the open market (i.e. sales other than sales in H&FW Department) during last three financial
years (see – Annexure-III). The sales must have relevance to the product he is quoting.
6
This criterion will be used to exclude those Tenderer who do not have at least 10% of the
production sold in the open market during the preceding three financial years.
16. RATE:
a. Rates are to be quoted for items as per the list of the Catalogue as provided in Table above.
b. Rate should be quoted in decimal coinage stating the particular item as per Catalogue of the
Tender proposed to be supplied inclusive of all incidental charges including FREE DOOR
DELIVERY to the Central Medical Stores, 141, Acharya J.C. Bose Road, Kolkata – 14 or 243,
Rabindra Sarani, Kolkata – 700003 and other purchasing health institutions under the Dept. of
Health & Family Welfare, Govt. of West Bengal, situated anywhere in the state. Sterile items are
to be transported in such packaging so that there is no damage to the primary packaging during
the transportation process.
c. Rates quoted in respect of items shall not exceed the controlled price and/ or M.R.P. (maximum
retail price) fixed by GOI wherever it is applicable.
d. Rates shall be valid throughout the period to be covered by the contract to be executed with
successful tenderers along with any extensions as may be made by the competent authority
from time to time.
e. THE BASIC RATE PER ACCOUNTING UNIT should be furnished inclusive of Entry Tax, Customs
Duty (if applicable), Transportation Cost, Insurance, Freight, testing charges, Incidental Charges
etc. but excluding of VAT/CST, Excise Duty & Cess etc. which shall be quoted separately in the
template for Bill of Quantities (BOQ).
f. Percentage of Excise Duty, CESS etc, Percentage of VAT/CST to be mentioned in the appropriate
Column of the template for Bill of Quantities. Manufacturing capacity per month is to be
mentioned in the appropriate column of the BOQ.
17. ORDER & SUPPLY:
I.
Orders for the supply of the approved products will be placed with the successful tenderers after
the execution of the agreements, and such supply shall have to be made in such instalments as may
be fixed or spread over the period to be specified in the supply orders to be made in pursuance of
the agreements. The successful tenderer will have to supply within the specified time schedule that
had been assured at the time of selection as supplier
II.
All supplies will have to be completed by door delivery within maximum 45 days from the date of
order in the SMIS System from the procuring units. NO RELAXATION ON ANY ACCOUNT WILL BE
ALLOWED FOR CONDONING DELAYED SUPPLIES. In addition to physical order, the selected vendors
would have access to the Vendor Portal from which, the procurement order, Goods Received notes
and Bill status can be seen on line.
III.
The permissible time period between the date of manufacture and the date of supply of the items
should not be more than 1/6 the of the whole life period. No delivery will be taken of any drug if the
date of manufacture and the date of expiry are not written on each and every unit supplied.
IV.
To ensure sustained supply without any interruption for facilitating prompt patient care services,
the DDHS (E&S), Central Medical Stores, Kolkata with the approval of the Tender selection
Committee reserves the right to split orders for supplying the requirements among more than one
tenderers provided that, the rates and other conditions of supply are equal and with sufficient
grounds. In case of non-supply/less supply of any item by any approved lowest quoted firm, the
DDHS (E&S), Kolkata can ask for willingness to L2 / L3 / L4 etc firm to supply at L1 rate (lowest
approved rate) and prepare the rate schedule with the same item in L1 rate sequentially till 120% of
the estimated requirement are met.
7
18. LABELLING:
All supplies of articles in drugs section should invariably contain the following information on its label
and the carton.
One information should not be overlapped by any other information needed to be furnished.
a. Pharmacopoeia name.
b. Manufacturing date.
c. Expiry Date.
d. Name & address of Registered Office of Manufacturers and place of manufacture.
e. Manufacturing Licence Number.
f. Batch Number
g. All Chemicals quoted/supplied by tenderer MUST CONFORM TO B.P, U.S.P, I.P and N.F.I –III
specification as noted against the item(s) in catalogue as applicable. For off and on change of
specification like BP., I.P. etc, favourable documents need to be produced to the purchasing
authority for acceptance.
h. Month and Year of supply.
i. The bottle label & carton should invariably marked with
For C.M.S Supply
….. “C.M.S. supply. Not for sale”
For supplies to decentralized units
….. “W B.Govt supply. Not for sale”.
Note A: “The MRP Rate Should not be printed in the Strips, Bottles, Vials, Pack etc.”
Note B: “Any information like Manufacturer’s Name & Address is strictly prohibited to be inscribed/
printed in any part of the wall of the bottle and cork.”
19. MANUFACTURING AND PACKAGING:
a) Packing of medicine (tablets, capsules, solid & liquid preparation), and Lab Chemicals with standard
packing materials
1. The rigid PVC used in blister packing should be of not less than 250 micron
2. All glass bottles should be new neutral glass.
3. Ointments should be packed in liquidized Aluminium Tubes.
4. Small Tablets packed in blisters should be packed to facilitate easy removal of the tablet without
breaking / crushing.
5. All plastic containers should be made of virgin grade plastics.
6. All plastic jars above 450Gms / ml should carry an inner plastic lid.
7. Liquids and Drops should be packed with plastic dispensers
b) Corrugated package box size limited to (12’’ H x 24”L x 24”W).
1. No corrugated box with contents should weigh more than 15 kgs (7 kgs in case of ointments and
fragile materials)
2. The inner lining shall be not less than 120 gsm and outer carton not less than 150 gsm.
3. The non glass bottle containing cartons shall be of at least 5 ply with bursting strength not less than
9 kg/sq cm
4. Glass bottle containing cartons shall be of at least 7 ply with bursting strength not less than 12 kg/sq
cm
5. No box should contain mixed products or mixed batches of the same product.
6. The product label on the cartoon should be large at least 15 cms x 10 cms dimension. It should carry
the correct technical name, strength or the product, date of manufacturing, date of expiry, quantity
packed and net weight of the box.
20. DRUG TESTING:
(a) Dy. Director of Health Services (E&S), West Bengal and the heads of the direct demanding units
and decentralized stores will be at liberty to get the supplied products tested at Govt. selected/
empanelled laboratory. Such testing will be in addition to tests that should be done by any
authority exercising statutory powers of drug testing. The tenderer shall be bound to destroy the
8
defective & non-standard batch(s) as per assay and other quality test report under pharmacopeia
norms. The tenderer shall be bound to replace the defective batch or batches if found defective
as per wrong packaging or labeling. The cost of procurement of such non-standard Item(s) or
defective batch(s) will not be paid or will be deducted from the security deposit and/or from the
current or pending bills of that supplier or from the performance bank guarantee. Moreover,
action under relevant Rules of the Drugs and Cosmetic Act will also be taken.
In no circumstances request by the suppliers for replacement of non-standard Item(s) found
defective or sub standard in the quality test will be entertained.
(b)
A sum @ 2% of bills exclusive of Govt. tax & duties will be deducted from the bills of the
supplies of medicine by C.M.S./ all D.R.S. / other direct demanding units and deposited in the
respective budget head to meet cost of handling and testing charges.
(c) Each installment of supply of products must be accompanied with a test certificate from a GLP
certified laboratory but these provisions may be relaxed for this tender only. The full name and
qualification and the attested signature of the certifying chemist is to be submitted in a separate
sheet.
(d) Central Medical Stores will depend on testing reports obtained from empanelled laboratory as per
norm for nondrug item also.
21. WITHDRAWAL /CANCELLATION & PURCHASE POLICY OF TENDERING AUTHORITY:
The tendering authority reserves the right to withdraw any item from the tender at any stage. The
selection of such item, if already made in favour of any Tenderer, shall be treated as cancelled.
i)
ii)
iii)
iv)
v)
The tendering authority reserves the right to reject or accept any tender or part thereof at
any stage or to split any tender without assigning any reason. Withdrawal of tender or any
revision after submission of tender by the Tenderer will not be allowed.
The tendering authority reserves the right to accept or reject any tender, in part or in full,
without assigning any reason.
Purchase will, however be made following the existing purchase policy of the Govt of West
Bengal and its amendment(s) made from time to time. The purchase policy of the State
Government as provided in the West Bengal Financial Rules, the policy of price preference
in particular incorporated under Notification No. 10500-F dated 19.11.04 should be
observed in considering the tenders.
The tendering authority reserves the right to purchase any item of the Catalogue at the
approved rate from any outsider (Non- Tenderer) during the tender period in case of
emergency, if the tenderer fails to supply such items on short notice,
The tendering authority reserves the right to procure any item, of the tender directly from a
state/ Central Govt. undertaking even if a tender for the same has been offered/ accepted.
22.
NO- CONVICTION CERTIFICATE:
No conviction certificate is to be submitted from the Drug Controlling Authority of the State where
the manufacturer is registered for last three years. He will also submit an affidavit in the prescribed
Pro-forma attached herewith from Notary/ first class Judicial Magistrate/Executive Magistrate.
23.
PENALTY CLAUSESIT SHOULD BE REALISED BY ALL THE TENDERERS THAT THE ITEMS INCLUDED IN THE TENDER
CONSTITUTE AN IMPORTANT PART OF THE ESSENTIAL MEDICINES REQUIRED FOR THE TREATMENT
OF PATIENTS. THIS IS MORE SO IN CASE OF SERIOUS AND EMERGENCY PATIENTS. THERE CAN BE NO
RELAXATION IN THE QUALITY AND TIMELY SUPPLY OF THESE ITEMS UNDER ANY CIRCUMSTANCES,
AS THIS WOULD SERIOUSLY ADVERSELY AFFECT PATIENT CARE SERVICES. TENDERERS ARE
9
THEREFORE ADVISED TO CAREFULLY ASSESS THEIR MANUFACTURING ABILITY AND CAPABILITY FOR
ENSURING TIMELY SUPPLY OF THE ASSURED QUANTITIES AS PROVIDED IN TABLE 1 ABOVE, PRIOR
TO PARTICIPATING IN THIS TENDER.
A) In case of supply of the sub-standard items found in the quality test as per quality assurance
norms, the detective batch /batches determined by the appropriate authority will not be
returned to the tenderers for replacement but will be destroyed and the payment of the
defective batches will not be made to the supplier or if paid in the meantime, is to be
deducted from the pending bills of the tenderer or from performance bank guarantee.
B) In case of supply of defective item found in respect of packaging or lebelling, tenderer will
be asked to replace the same.
C) In addition to rejection of the supply, the Dy Director of Health Services (E&S) W.B and the
heads of direct demanding units will have the right to cancel the supply order wholly or in
part, to forfeit security deposit and to recover the loss, if any, of the Govt. by making
deductions from any pending claim of the supplier/ Security Deposit or Performance Bank
Guarantee, as may be deemed fit. Such Penalty for supply of a drug falling within the
meaning of adulterated/ spurious/ misbranded under Section 17 (A), 17 (B) and 17 (C) of
the Drugs and Cosmetic Act will be in addition to action which may be taken by police, the
Drug Control Authority or by tendering authority of the State Govt or the Govt of India or by
any individual under the law of the land.
D)
Debarment from participation in next tender processes of the Health & Family Welfare
Department: The tender selection committee reserves the right to declare a firm/ Company
blacklisted for three (03) years due to the following reasons:
If the supplier
i)
Withdraws from agreement after achieving the “Lowest Quoted Tenderer”
ii)
Failure in supply throughout the state within the stipulated period for five occasions
during the tenure of the tender period or its extensions.
iii)
In case of supply of spurious drugs (as applicable)/, along with proceedings under
the provisions Drugs and Cosmetic Act, 1940 and Rules framed there
iv)
For supply of Non – standard items as per quality test within tender period as
determined by the testing of the item as per discretion of Tender Selection
Committee in respect of particulars items only.
v)
In consequence of submission of false or fabricated documents by any firm/
company for participating in the tender, if proved later on.
vi)
Quoting absurdly high or low rate in the opinion of Tender selection Committee,
with the intention to vitiate the tender process. The assessment of too low or too
high will be made by a team of Health officials in the context of NPPA norms or any
other norms under Govt.
vii)
Supply of items with short expiry dates in violation of Clause 15 (iii) on more than
three occasions.
viii)
Submission of tender for the product /products for which the concerned company /
its Principals/ or sister concern (where its Principals or Promoters have more than
10% shares) has been blacklisted either by the state Government/ other State /
Central Government Organization for any reason whatsoever
ix)
Submission of tender during the period of blacklisting of Concern / Company / its
Principals/ or sister concern (where its Principals or Promoters have more than 10%
shares) either by Tender Inviting Authority or by any State Government or by other
State/Central Government
The H&FW Department will have the right to inspect the manufacturing units of the tenderers
before accepting the rates quoted by them or at any point of time during continuance of the tender
and the Department will also have the right to reject tender or terminate/ cancel the purchase
order(s) and/ or not to re- order based on the adverse reports brought during those inspections.
10
E) Financial Penalties for deficiencies in services/supplies during the period of the tender and its
subsequent extensions:
1. For delay in the supply of items ordered beyond the stipulated date. The procuring
authority has to justify with proof of receipt of supply order along with receipt of way bill (wherever
applicable for invoking this clause). Part supply will not be considered as supply in full unless
specified in the supply order.
a. In respect of all consignment, stipulated period will be 45 (Forty Five) days from the
date of order generated in SMIS. The Order(s), generated from the SMIS will carry the
same status that of Signed Order(s).
b. If the supplies are not made in full within the stipulated period of placing the order,
0.5% of the basic cost of the materials not supplied will be deducted from the existing /
pending bills of the supplier per day’s delay up to 60 days.
c. For delays beyond 60(Sixty) days, the work order for the non- supplied portion will be
considered as cancelled straightaway.
d. However, if the stipulated period ends on Sunday, Saturday or, Govt. Holidays, supply
should be made on the next working day and in that case, no penalty would be
chargeable.
e. The provision of Penalty is system generated and cannot be waived in any case.
f. The Firm will be blacklisted after issuance of a Show cause letter for such delay beyond
60 days in five occasions. In that case, the firm quoting L2, will be selected.
2. For firms who fail to supply the full order on five occasions for any particular item within the
stipulated time within the tender period and its extensions- the Performance Bank Guarantee
deposited for the item concerned will be forfeited and the Principal firm will be debarred from
participation in the CMS, DoHFW or WBMSC tenders for the next three years.
3. Supply of items with short expiry dates in violation of Clause 17 (iii) on more than two
occasions - 5% of the cost of the items or Rs 50,000, whichever is higher will be deducted from the
bills.
4. The names of the defaulting suppliers will be put up in the Departmental website
Enhancement of rates of raw materials etc or the fact that the tender period has been extended will
not be acceptable as a plea for not supplying the materials within the stipulated period as provided
in the work order
F)
24.
APPEAL:
Appeal against the decision of the Dy. Director of Health Services (E&S), West Bengal and the head
of the direct demanding units to impose such a penalty will lie with Tender Selection Committee.
Review against the decision of the T.S.C. will lie with Health & F.W. Deptt of the Govt
The Special Secretary/Secretary/Principal Secretary will be the appellate authority within the
Department of Health & Family Welfare, Government of West Bengal. Before imposing any penalty
as per clauses 21, 22and 23 the concerned supplier may appeal to the authority citing the proper
reasons for non- imposing the penalty as stated.
PENALTY FOR FORMATION OF CARTEL OR FURNISHING OF FRADULENT/ MISLEADING DOCUMENTS:
If during the tender process or at any state during the validity of the tender period, it is found that a
Tenderer(s) has formed a cartel in what so ever form or name to fix up the rates or suppliers to the
detriment of the fairness of the tender process, penal measures shall be initiated. Similar penal
measures shall also be initiated against those tenderers who have submitted false/ misleading/
fraudulent documents or made incorrect declarations. The penal measure will be
i)
Forfeiture of Earnest Money
ii)
Forfeiture of Performance Bank Guarantee if enlisted as a supplier
iii)
Cancellation from the approved list of suppliers and debarment from further supply orders
iv)
Black listing from all Departmental tenders (called by the CMS or others) of the Tenderer, the
Principals of the firm(s) and the concerned distributor(s) for a period of three years
11
25.
AGREEMENT:
On a tender being accepted, intimation of acceptance will be forwarded through departmental
website by the Dy. Director of Health Services (E&S) W.B. After communication of the same, the
Tenderer and the selected distributor (in the event of distributor to receive order and payment in
his name) will have to execute agreement in the prescribed form along with submission of requisite
amount of performance Bank Guarantee with the Dy. Director of Health Services (E&S) W.B., within
ten (10) days from the date of issue of invitation. In case any direct purchasing unit wishes to go for
a separate agreement the head of the purchasing unit must get written permission to that effect
from his controlling authority. This present document and the tender forms filled in by the Tenderer
or copies thereof in so far as they are not inconsistent with these terms & Conditions will be
incorporated as part of the agreement. Such agreement will be binding on the Tenderer and
distributor.
26. VALIDITY PERIOD OF AGREEMENT:
The contract period will be for a period up to 31st May, 2015 which may be extended up to six
months with prior approval of the Department of Health & Family Welfare, Government of West
Bengal, if necessary.
27. ‘PERFORMANCE BANK GUARANTEE’
i.
The performance bank guarantee will be mandatory for all approved suppliers and will not
be waived in any case.
ii.
The successful tenderers shall be required to furnish the “Performance Bank Guarantee”
a. For Items under Table 1 A (List of Drug Items) @ 2% of assessed base rate of Annual
requirement, subject to a minimum of Rs. 30,000 and maximum of Rs. 5,00,000 per
item and for which the Tenderer has been selected as supplier.
b. For Items under Table 1 B (List of Laboratory Kit, Chemicals and Reagent) @ 2% of
assessed base rate of Annual requirement, subject to a minimum of Rs. 25,000 and
maximum of Rs. 1,00,000 per item and for which the Tenderer has been selected as
supplier.
iii.
If out of State manufacturer proposes that order & payment are to be made in the name of
an authorized distributor, the distributor then should have to submit “Performance Bank
Guarantee”
a. For Items under Table 1 A (List of Drug Items) @ 1% of assessed base rate of
requirement with minimum of Rs. 10,000 and maximum of Rs. 1,00,000 per item(s) for
the distributors.
b. For Items under Table 1 B (List of Laboratory Kit, Chemicals and Reagent) @ 1% of
assessed base rate of requirement with minimum of Rs. 10,000 and maximum of Rs.
50,000 per item(s) for the distributors.
iv.
v.
vi.
The Performance Bank Guarantee from any nationalized/ scheduled bank in India
acceptable to the Government of West Bengal should be submitted to the Dy. Director of
Health Services (E&S), West Bengal, within 15 (fifteen) days from the date of acceptance of
tender.
If Agreement has not been executed along with submission of performance bank Guarantee
within 15 days from the date of acceptance of tender, the candidature will be cancelled and
the next Bidder will subsequently be accepted.
The Performance Bank Guarantee will be liable to forfeiture as enumerated in Clauses 23
above.
12
28. INSPECTION:
The competent authority may visit any factory at any day at any time in a regular basis for
inspection. In case of tenderer bag L1 status for more than 3 items, physical inspection will follow to
adjudge its production capability and assured supply and take decision accordingly for L1 status.
29. PAYMENT TERMS:
Payment will be made through e payment system through ECS/RECS/RTGS after execution of due
supply as ordered subject to :
1. Submission of Performance Bank Guarantee in terms of Clause 27 and subject to penalty clause
in terms of Clauses 23 & 24.
2. Supply of the materials as per specification as provided in the tender documents and the
catalogue
3. Supply of the materials within the supplied period as specified in the work orders
4. The status of orders, Goods received note and payments will be available on-line for the
vendors in the vendors portal in the Departmental website www.wbhealth.gov.in : Vendor
Portal.
5. On being selected, the successful vendors will have to submit one application stating the name
of the payee/ recipient, Bank account no with MICR code, IFSC of the payee/recipient for
making e payment. No manual payment will be made.
30. SPECIAL TERMS & CONDITIONS in respect of Kits used in ICTCs Viz. HIV (Rapid) Test Kit I, Kit II,
Kit III , Whole Blood Finger-prick Test etc.
i.
The shelf life of the kits has to be defined as 60% of residual life or a shelf life of 12
months at the time of dispatch to the consignee, whichever is more.
ii.
The supplier/local agent should have the facility to store kits at 2 degree to 8 degree C
iii.
The supplier should supply kits for at least 600 tests free of cost from each lot for
random evaluation at the identified laboratories for pre-dispatch lot verification.
Protocols for each batch to be attached.
iv.
The kits should not be using the comb device as the feasibility study reported by NARI,
Pune has difficulty in performances using the comb tests in field conditions.
Minimum Requirements:1. Product and package specifications
1.1
The required packing standards and labeling must meet the requirements given
in this Technical Specification and Part.
1.2
Not only the goods but also the packaging components should also meet
specifications suitable for use in a climate similar to that prevailing in the
country of the Purchaser. All packaging must be properly sealed and tamperedproof.
1.3
All labeling and packaging inserts shall be in the language requested by the
Purchaser or English if not otherwise stated.
1.4
Goods requiring refrigeration or freezing for stability must specifically indicate
storage requirements on labels and containers and be shipped in special
containers to ensure stability in transit from point of shipment to port of entry.
1.5
Upon award, the successful Supplier shall, on demand, provide a translated
version in the language of the bid of the prescriber’s information for any specific
goods the Purchaser may request.
2. Product Information
2.1 The following information will be required for each pharmaceutical product
offered by the Bidder :
i)
International Non-Proprietary Name (INN), if applicable;
ii)
Brand name (if it appears on label);
iii)
Name and address of the manufacturer;
iv)
Country of origin; and Compendia standards
13
2.2
2.3
Upon award, the supplier shall, on demand, provide a translated version in
English, of the prescriber’s information for any specific product, the Purchaser
may request.
Failure to include any of this information, at the discretion of the Purchaser, may
render the bid non-responsive
3.
Expiration Date
All products must indicate the dates of manufacture and expiry. In addition,
unless otherwise stated in Part A of these Specifications, all products must
arrive at the final consignee point with a remaining shelf life of at least fivesixths (5/6ths) of the total stipulated shelf life at the time of manufacture.
4.
Recalls
If products must be recalled because of problems with product quality as a
result of quality check carried out during the life span of the drug or adverse
reactions to the pharmaceutical, the supplier will be obligated to notify the
purchaser providing full details about the reason leading to the recall and shall
take steps to replace the product in question at its own cost with a fresh batch
of acceptable pharmaceuticals, or withdraw and give a full refund if the product
has been take off the market due to safety problems.
5.
Labeling instructions
5.1 The label for each Goods shall include:
(a)
the Purchaser’s logo and code number and any specific color coding if
required.
(b)
content per pack
(c)
instructions for use
(d)
special storage requirements
(e)
batch number
(f)
date of manufacture and date of expiry (in clear language, not code)
(g)
name and address of manufacture with license number
any additional cautionary statement
5.2 The outer case or carton should also display the above information
6.
Details of Packing/Cases
6.1
All cases should prominently indicate the following:
(a)
The generic name of the product;
(b)
date of manufacture and expiry (in clear language not code);
(c)
batch number; and quantity per case
6.2
No case should contain same item from more than one batch.
7.
Unique Identifier
The Purchaser shall have the right to request the Supplier to imprint a logo on
the containers used for packaging and in certain dosage forms such as tablets
and this will be indicated in Part A of the Technical Specifications. The design of
such logo shall be provided to the supplier at the time of Contract award.
8.
Qualifications of Manufacturer
The bidder shall furnish a certificate from the competent FDRA that the
manufacturer of the pharmaceutical r vaccine product covered by this Invitation
for Bids is licensed to manufacture these products.
14
9.
Standards and Quality Assurance Requirements
9.1
All products must:
a.
Meet the requirements of manufacturing legislation and regulation of
pharmaceuticals or vaccines in the country of origin
b.
Conform to all the specifications contained herein; and
c.
Must undergo strict raw material inspection, in process checks,
appropriate material handling to eliminate cross contamination (of
molecules) and final product testing to ensure quality and consistency of
the products.
9.2The Bidder is required to furnish to the Purchaser:
(a) With each consignment, a certificate of quality assurance test results
concerning quantitative assay, chemical analysis and other tests, as
applicable to the product being supplied and part A of these
Specification.
(b) Assay methodology of any or all tests if requested.
(c) Evidence of basis for expiration dating and other stability data on the offered
package (as per climatic conditions prevalent in India) concerning the
commercial final package upon request.
(d) Package integrity test results
9.3 The Bidder will also be required to provide the purchaser with access to its
manufacturing facilities to inspect its facilities, quality control
procedures for raw materials, test methods, in-process tests, and
finished Goods
31. Dates & Information:
Sn
Items
01.
02.
Date of uploading of N.I.T. Documents (online)
Pre BID Meeting in the chamber of the DDHS(E&S), Central
Medical Stores, 141, A J C Bose Road, Kolkata 700 014
Documents Download Start Date (Online)
Bid Submission Start Date
Date of hoisting of documents at departmental
website(www.wbhealth.gov.in)
Bid Submission Closing Date (Online)
Last date of submission of original copy for the cost of earnest
money deposit (off line)
Bid Opening Date (Online) – Technical Bid i.e., Bid A
Date of uploading list for technically qualified bidder (online)
Date of opening of Financial Bid i.e., Bid B
Date of uploading of list of bidders along with the approved rate
03.
04.
05.
06.
07.
08.
09.
10.
11.
Publishing date(s)
02.01.2015
05.01.2015 at 12.00 noon
02.01.2015
02.01.2015
02.01.2015
22.01.2015 at 5:00 p.m.
22.01.2015 at 4:00 p. m
27.01.2015 at 12:00 noon
27.01.2015 onwards
27.01.2015 onwards
27.01.2015 onwards
32. DDHS (E&S) RESERVES THE RIGHT TO CHANGE THE ABOVE SCHEDULE IN CASE OF ANY EXIGENCIES
AFTER PUTTING UP A NOTICE IN THE DEPARTMENTAL WEBSITE AND CMS NOTICE BOARD.
33. If any change in Opening the financial bid / uploading of list of bidders as per schedule be decided
will BE NOTIFIED LATER ON.
No objections in this respect will be entertained raised by any Bidder who will present during opening of
bid, or from any Bidder who will absent at the time of opening of Financial Bid. No informal tenderer will
be entertained in the Bid further.
15
34. During the scrutiny, if it comes to the notice to tender inviting authority that the credential or any
other paper found incorrect/ manufactured/ fabricated, that bidder would not allowed to participate in
the tender and that application will be out rightly rejected without any prejudice.
35. A HELP DESK is set up in the office of the Deputy Director of Health Services (E&S), Central Medical
stores, 141, A J C Bose Road, Kolkata – 700 014 to help and guide the prospective bidders about their
registration, holding of Digital Signature Card and allied matter. Prospective bidders may contact
personally or over phone vide phone no (033) 2265 4419 or mail their querries in the following e mail
addresses :
a. [email protected]
b. [email protected]
36. The Tender Selection Committee reserves to right to cancel the N.I.T. due to unavoidable
circumstances and no claim in this respect will be entertained.
Deputy Director of Health Services (E&S)
Central Medical Stores
141, A J C Bose Road, Kolkata – 700 014
16
Table - 1
(List of Items with Tentative Annual Requirement )
Sn
Catalogue No.
Item Name
Acc. Unit
Tentative
annual
requirement
based on
accounting
unit
A. List of items under Drugs :
1
11.13(a)/T
Amikacin Inj IP 100 mg/2 ml vial
2
11.13(a)/T
3
30,000
Amikacin Inj IP 250 mg/2 ml vial
Box of 10 Vials
Box of 10 Vials
11.13(a)/T
Amikacin Inj IP 500 mg/2 ml vial
Box of 10 Vials
80,000
4
24.05/T
Omeprazole Cap 20 mg
Strip of 10 Capsules
5.
2.08(a)/P-1
Tramadol HCL Inj 100 mcg/2ml Amps
Box of 10 Amp
40,000
6.
35.01(a)/P-1
Box of 10 Amp
7500
7.
18.09(a)/S
Ergometrine Maleate Inj BP 0.2mg/ml in
Amp
Digoxin Tab IP 0.25mg
Strip of 10 Tabs
20,000
8.
2.12(a)/P-1
Diclofenac Sodium 50mg Tab
Strip of 10 Tabs
30,000
9.
2.12/P-1
Diclofenac Sod Inj IP 75mg/3ml Amp
Box of 10 Amps
30,000
10
39.04(a)/S-S
Vincristine Inj 1mg/ml
Vial of 1 Mg.
11
22.02/T
Bisacodyl Tab
Strip of 10 Tabs
50,000
12
6.02(e)/S-S
Cefaperazone + Sulbactum 1.5gm Inj.
Vial
20,000
13
N-18.34/
Clopidogrel 75mg Tab.
Strip of 10 Tab
20,000
14
11.20(a)/P-1(a)
Cefadoxim Proxetil 200 mg tab
Strip of 10 Tab
20000
30,000
1,50,000
8000
B. List of Laboratory Kit, Chemicals and Reagents :
1 43.04/
Absolute Alcohol I.P.
Bottle of 500 ml
1500
2 43.04(b)/
Acetone free Methyl Alcohol
Bot. of 500 ml
2000
3 41.02(c)
Activated Gluteraldehyde Solution
2.45% for Instrument Sterilisation
Cont. of 5 Litres
500
4 K/01
5 K/04
AFP ELISA KIT
96 Wells
100
Ammonia - Test Kit
1 ml
6 K/11
ANTI CCP ELISA KIT
96 Wells
100
7 K/12
Anti D Serum (IgG)
10ml Vial
1000
8 K/15
Anti DSDNA-(Elisa kit)
96 Test
1000
9 K/16
Anti H Lectin
5ml Vial
1000
10 K/17
Anti Human Globulin (Coombs)
Vial of 5 ml
1000
11 K/20
Anti Nuclear Factor Rapid Test Kit
Per Test
100
12 K/23
ASO Elisa Kit
96 Test
100
13 ABD-07
Aztreonam Antibiotic Disc
Per 50 Disc
350
14 ABD-08
Bcitracin Antibiotic Disc
Per 50 Disc
350
15 43.34/
16 K/26
Boric Acid IP.
Bot. of 500 gm
Ca-125 Kit
96 Test
17
50000
1000
100
17 K/28
CD4 Reagent Kit I - 100 kit in one box
for partec CD4 machine
Box of 100 Kit
80
18 K/29
CD4 Reagent Kit II - 50 kit in one box
for BD fax count machine
Box of 50 Kit
350
19 K/30
CD4 Reagent Kit III - 50 kit in one box
for BD fax caliber CD4 machine
Box of 50 Kit
300
20 K/31
CEA ELISA KIT
96 Wells
100
21 ABD-13
Cefdinir Antibiotic Disc
Per 50 Disc
350
22 ABD-14
Cefepime Antibiotic Disc
Per 50 Disc
350
23 ABD-17
Cefoperazone/ Salbactam Antibiotic Disc
Per 50 Disc
350
24 ABD-19
Cefpirome Antibiotic Disc
Per 50 Disc
350
25 ABD-20
Cefpodoxime Antibiotic Disc
Per 50 Disc
350
26 ABD-21
Cefprozil Antibiotic Disc
Per 50 Disc
350
27 ABD-23
Ceftizoxime Antibiotic Disc
Per 50 Disc
350
28 ABD-24
Ceftriaxone /Salbactum Antibiotic Disc
Per 50 Disc
350
29 ABD-28
Cephalexin Antibiotic Disc
Per 50 Disc
350
30 41.16(b)/
Cetrosterile Disinfectant Chemical
lotion
Chloramphenicol Antibiotic Disc
Bottle of 500 ml
100
Per 50 Disc
350
32 K/34
33 ABD-36
Control Plasma N
1 ml
Co-trimoxazole Antibiotic Disc
Per 50 Disc
350
34 44.17(a)/
35 44.17(b)/
Detergent 1000gm, IS 4955
Jar of 1kg
500
Detergent 500gm, IS 4955
Jar of 500 gm
500
36 K/42
DHEAS ELISA KIT
96 Wells
100
37 K/44
EQAS Immunossary
1 ml
38 L/16
Esbachs Reagent
Bottle of 500 ml
39 K/45
Estradiol Elisa Kit
96 Wells
40 43.03(a)/
Ethanol 95% v/v (Rectified Spirit)
Bottle of 100 ml
20000
41 43.03/
Ethanol 95% v/v (Rectified Spirit)
Bottle of 500 ml
40000
42 K/46
Extran Test Kit
Bottle of 500 ml
500
43 41.09/
44 K/48
Formaldehyde Solution I.P.
Bottle of 500 ml
1000
fPSA - Elisa
96 wells per kit
75
45 K/50
FT3- Elisa
96 wells per kit
275
46 K/51
FT4- Elisa
96 wells per kit
275
47 ABD-39
Furazolidone Antibiotic Disc
Per 50 Disc
350
48 21.03/P-1
Gamma Benzene Hexachloride I.P.
Bottle of 500 ml
1000
49 K/52
Gamma Glutamyl Tranpepdase kit (
IFCC Method )
Per Kit
1000
50 41.06/
Gentian Violet N.F.
Bottle of 25 gms
1000
51 L/20
Glycerin I.P.
Bottle of 500 gm
500
52 L/21
Glycin Irrigation Fluid
3 Lit.
100
53 L/22
Haemodialysis Fluid with Bi-Carb
10 Lit
5000
31 ABD-31
18
1000
10000
1000
100
54 L/23
Hamatoxyllin Eosin Stain Powder
Per 5 gm.
55 K/59
Per Kit
HbsAg (Elisa) Kit
Specification:
a. The kit should be third generation
Elisa kit with solid phase micro plate
Elisa.
b. The kit should be based on „Sandwich
principle of Enzyme Linked Immuno
sorbent Assay‟ (Elisa) for the detection
of Hepatitis B Surface Antigen (HBs Ag)
in human serum or plasma.
500
6250
c. The test kit should detect all known
sub-types.
d. The Elisa plate should be coated with
Anti-HBs Antibody ( mouse
monoclone)
e. The kit should have sensitivity of
equal to or more than 99.8%.
f. The kit should have specificity of
equal to or more than 98%.
g. The assay should have reactive and
non-reactive control with each kit.
h. Adequate literature detailing the
component, methodology, validity
criteria, performance characteristics,
storage condition and expiry date
should be provided with each kit.
i. The shelf-life of the kit should have
minimum of 12 (Twelve) months at the
port of dispatch or the consignee‟s end,
whichever is applicable.
56 K/61
57 K/62
j. The manufacturer/authorized agent
should ensure maintenance of coldchain during storage and transport at
2°C – 8°C.
k. The kits should have approval of the
statutory authority in its country of
origin. In case of imported kits, it
should have been registered and
licensed in India by Drugs Controller
General( India).
l. The package size should be 96 wells
per kit
HCG Elisa Test Kit
HCV (Elisa) Kit
Specification:
19
Per Kit
1000
Per Kit
6250
a. Microplate ELISA with recombinant
/ synthetic peptide antigens for core,
NS3, NS4 and NS5.
58 K/66
b. Should provide sero conversion data
of the kits from WHO accredited
centres.
c. Adequate literature detailing the
components, methodologies, validity
criteria, performance characteristics,
storage conditions, manufacturing and
expiry dates should be provided with
each kit.
d. Should have a sensitivity of 99.8%
and above and specificity of 98% and
above.
e. Shelf life should be minimum of 12
(twelve) months at the port of discharge
or consignee‟s end whichever is
applicable.
f. The kit procured should have
approval of the statutory authority in its
country of origin. In case of imported
kits it should have been registered and
licensed in India by DCG (I).
g. In case of indigenous manufacturers
they shall have license issued by the
competent authority defined under
Drugs & Cosmetics Act, 1940, after
appropriate evaluation by the centres
approved by DCG (I).
h. The supplier / local agent should
have facility of storage of kits at 2° C –
8°C.
i. The Kit size should be 96 wells per
kits
Hepatitis A test Kit
96 Wells
500
59 K/67
Hepatitis E test Kit
96 Wells
500
60 K/68
HIV (Elisa) Kit
Specification:
a. Should be solid phase microplate ELISA
using HIV I & II recombinant and/or
synthetic peptide antigens.
Per Kit
b. The assay should detect HIV-I & HIV-II
antibodies.
c. The assay should detect antibodies to
all sub-types of HIV-I.
d. The assay should be able to detect
antibodies of HIV-I & HIV –II during early
sero-conversion period. Evidence based
sero-conversion data should be from
WHO accredited centers.
20
6250
e. The assay should have reactive and
non-reactive controls with each kit.
f. The kit should have a shelf life of
minimal 12 months at the port of
discharge or consignees end, whichever
is applicable.
g. Adequate literature detailing the
components, methodologies, validity
criteria, performance characteristics,
storage conditions, manufacturing and
expiry dates should be provided with
each kit.
h. The kit procured should have approval
of the statutory authority in its country of
origin. In case of imported kits it should
have been registered and licensed in
India by DCG(I).
i. In case of indigenous manufacturers
they shall have license issued by the
competent authority defined under Drugs
and Cosmetics Act, 1940, after
appropriate evaluation by the centers
approved by DCG(I).
j. The assay should have sensitivity level
at 99.8% and above and specificity level
at 98% and above.
k. The manufacturer/authorized agent
should ensure maintenance of cold chain
during storage and transport at 2° C –
8°C.
l. The kit size should be 96 tests per kit.
61 K/69
HIV (Rapid) Kit
Specification:
a. The indigenous HIV antibody rapid
test kits should have a valid license
issued by the competent authority
defined under Drugs & Cosmetics Act,
1940 after appropriate evaluation by
centers approved by DCG(I). The
imported rapid test kits should have the
approval of the statutory authority in
the country of Origin / manufacture
and should satisfy the requirements of
Drugs & Cosmetics Act in India.
b. The assay should be able to detect
antibodies of HIV1, HIV2 and all the
subtypes by detection of antibodies by
the agglutination method.
21
Per Test
250000
c. The assay should have sensitivity of
99.5%or more and specificity of 98%or
more as per data from an identified
national reference laboratory.
d. The assay should have solid phase /
particles coated with synthetic and/or
recombination or both types of antigens
of HIV1 & HIV2.
e. Total procedure time should not be
more than 30 minutes.
f. The manufacturers should ensure
that:
i. The test kit should be packed such
that there is a provision to conduct
single test at a time;
ii. The assay components should
include HIV positive and negative
serum controls sufficient for conducting
20% of the tests (10% negative and 10%
positive controls); and
iii. The pack size of HIV rapid test kits
should not be more than 50 tests per kit.
g. The HIV rapid test kit should have a
shelf life of 12 months at the time of
dispatch to the consignee. The kits
should be sent by the shortest route in
cold chain.
h. The supplier should supply kits for at
least 22 kits free of cost from each lot for
random evaluation at the identified
laboratories for Pre-dispatch lot
verification. Protocols for each batch to
be attached.
i. The supplier / local agent should
have the facility to store kits at 2° C to
8° C.
j. Literature, detailing the components,
methodologies, validity criteria,
performance characteristics, storage
conditions, manufacturing and expiry
dates should be provided with each kit.
62 K/73
HIV (Rapid) Test Kit II - [BY ANY
OTHER PRINCIPLE EXCLUDING
AGGLUTINATION AND ENZYME
IMMUNO ASSAY]
Specifications:-
22
Per test
60000
1. The indigenous HIV antibody rapid
test kits should have a valid license
issued by the competent authority
defined under Drugs & Cosmetics Act.
1940 after appropriate evaluation by the
centres approved by DCG(I). The
imported rapid test kits should have the
approval of the statutory authority in
the country of Origin/manufacture and
should satisfy the requirements of
Drugs and Cosmetics Act in India.
2. The assay should be able to detect
antibodies of HIV-I and HIV-2 and all
the subtypes by detection of antibodies
by any other method excluding
agglutination and enzyme immune
assay.
3. The assay should have sensitivity of
99.5% or more and specificity of 98% or
more as per data from an identified
national reference laboratory.
4. The assay should have solid
phase/particles coated with synthetic
and/or recombination or both types of
antigens of HIV1 & HIV2.
5. Total procedure time should not be
more than 30 minutes.
6. The control dot/band should be able
to detect the presence of Human
Immunoglobulins and should not be
just a procedural control or meant for
merely checking the flow of reagents or
integrity of the antigen except in lots
using “Lateral flow through”
technology.
7. The manufactures should ensure that
a. The test kit should be packed such
that there is a provision to conduct
single test at a time without
compromising the quality of the
remaining part of the kit;
b. The assay components should
include HIV positive and negative
serum controls sufficient for conducting
20% of the tests (10% negative & 10%
positive controls); and
c. The pack size of HIV rapid test kits
should not be more than 50 tests per kit.
23
8. The HIV rapid test kit should have a
shelf life of 12 months at the time of
dispatch to the consignee. The kits
should be sent by the shortest route in
cold chain.
9. The supplier/local agent should have
the facility to store kits at 2 degree to 8
degree C
10. The supplier should supply kits for
at least 600 tests free of cost from each
lot for random evaluation at the
identified laboratories for pre-dispatch
lot verification. Protocols for each batch
to be attached.
Literature detailing the components,
methodologies,, validity criteria,
performance characteristics, storage
conditions, manufacturing and expiry
dates should be provided with each kit
63 K/76
HIV (Rapid) Test Kit III - [BY ANY
OTHER PRINCIPLE EXCLUDING
AGGLUTINATION AND ENZYME
IMMUNO ASSAY]
Specifications:1. The indigenous HIV antibody rapid
test kits should have a valid license
issued by the competent authority
defined under Drugs & Cosmetics Act.
1940 after appropriate evaluation by the
centres approved by DCG(I). The
imported rapid test kits should have the
approval of the statutory authority in
the country of Origin/manufacture and
should satisfy the requirements of
Drugs and Cosmetics Act in India.
2. The assay should be able to detect
antibodies of HIV-I and HIV-2 and all
the subtypes by detection of antibodies
by any other method excluding
agglutination and enzyme immune
assay.
3. The assay should have sensitivity of
99.5% or more and specificity of 98% or
more as per data from an identified
national reference laboratory.
4. The assay should have solid
phase/particles coated with synthetic
and/or recombination or both types of
antigens of HIV1 & HIV2.
24
Per Test
60000
5. Total procedure time should not be
more than 30 minutes.
6. The control dot/band should be able
to detect the presence of Human
Immunoglobulins and should not be
just a procedural control or meant for
merely checking the flow of reagents or
integrity of the antigen except in lots
using “Lateral flow through”
technology.
7. The manufactures should ensure that
a. The test kit should be packed such
that there is a provision to conduct
single test at a time without
compromising the quality of the
remaining part of the kit;
b. The assay components should
include HIV positive and negative
serum controls sufficient for conducting
20% of the tests (10% negative & 10%
positive controls); and
c. The pack size of HIV rapid test kits
should not be more than 50 tests per kit.
8. The HIV rapid test kit should have a
shelf life of 12 months at the time of
dispatch to the consignee. The kits
should be sent by the shortest route in
cold chain.
9. The supplier/local agent should have
the facility to store kits at 2 degree to 8
degree C
10. The supplier should supply kits for
at least 600 tests free of cost from each
lot for random evaluation at the
identified laboratories for pre-dispatch
lot verification. Protocols for each batch
to be attached.
Literature detailing the components,
methodologies,, validity criteria,
performance characteristics, storage
conditions, manufacturing and expiry
dates should be provided with each kit
64 44.03(a)/
Hydrogen Peroxide 11% w/v +diluted
Silver Nitrate 0.01% w/v
Jar of 1 litre
1000
65 44.03/
Hydrogen Peroxide Soln. (20Vol) I.P.
Bottle of 500 ml
1000
66 L/33
67 ABD-43
KOH Solution 10% L
100 ml Bot
100
Levofloxacin Antibiotic Disc
Per 50 Disc
350
68 ABD-44
Lincomycin Antibiotic Disc
Per 50 Disc
350
69 ABD-45
Lineazolid Antibiotic Disc
Per 50 Disc
350
25
71 43.21/
Magnesium Sulphate I.P.
72 K/86
Malaria Pf & Pv Combined Ag
Immunochromatographic kit
73 K/88
MB/BACT Antibiotic Suppliment Kit
100 kit
100
74 41.15(a)/P-1
Merbromin (liquid)
Bottle of 50 ml
500
75 ABD-47
Meropenem Antibiotic Disc
Per 50 Disc
350
76 ABD-48
Minocyclin Antibiotic Disc
Per 50 Disc
350
77 ABD-49
Moxifloxacin Antibiotic Disc
Per 50 Disc
350
78 41.17(a)/P-1(a)
O.T.sterilization solution for
fumigation/mopping, in powder form,
Composition :-Potassium Mono per
Sulphate (Triple Salt )- 40% to 50 %,
Sodium C 10-13 Alkyl benzene Sulphate 10% to 20% and Sodium Chloride - 1%
to 5%.
Bottle of 500 gm
79 ABD-54
Ofloxacin Antibiotic Disc
Per 50 Disc
80 K/91
81 ABD-57
pH paper range 1 to 14
50 strip
Pipercillin-Tazobactam Antibiotic Disc
Per 50 Disc
350
82 L/32
83 41.15(e)/P-1
Poly Sodium Citrate
Bot. of 500gm.
500
Potassium Permanganate I.P.
Bot. of 100 gm
1000
84 K/93
85 43.01/
Progesterone Elisa Kit
96 Wells
Puriffied Water I.P.
Jar of 5 litre
86 L/35
87 L/36
PYR Reagent
Bot. of 100 ml
100
PYR strip
per 100 strip
100
88 K/95
Rapid diagnostic kit for Kala-azar
pouch pack
50
89 ABD-59
Roxithromycin Antibiotic Disc
Per 50 Disc
350
90 L/38
91 L/40
SDA with CC
Bot. of 500 gm
100
Sodalime
Per Kg
92 L/42
Sodium Para Amino Salicylate (NaPAS)
80% Bio-Availability
Jar of 100 Gms.
500
93 41.17(b)/
Solution for instrumental sterilization in
powder form, Composition : Sodium
Perborate Monohydrate 50% w/w (0.26%
per acetic acid)
Teicoplanin Antibiotic Disc
Bottle of 810 gm
1000
Per 50 Disc
350
95 K/103
96 L/44
Testesterone Elisa Kit
96 Wells
100
Toludine Blue
Bot. of 25 gm
500
97 K/105
98 ABD-66
Total PSA Elisa Kit
Trimethoprim Antibiotic Disc
96 Wells
Per 50 Disc
100
350
99 K/111
VDRL Kit - latex kit
100 Test Per Kit
10 K/112
0
10 K/113
1
Vitamin D Elisa Kit
96 Wells
100
Whole Blood Finger-prick Test
Technical Specifications
Per Test
660000
94 ABD-62
26
Packet of 500
gm.
Per Test
500
750000
5000
350
10000
500
28000
1000
1000
1. The indigenous HIV antibody rapid
test kits should have a valid license
issued by the competent authority
defined under Drugs & Cosmetics Act.
1940 after appropriate evaluation by the
centres approved by DCG(I). The
imported rapid test kits should have the
approval of the statutory authority in
the country of Origin/manufacture and
should satisfy the requirements of
Drugs and cosmetics act in India. The
imported kits should also get evaluated
in our country.
2. The assay should be able to detect
antibodies of HIV-I and HIV-2 and all
the subtypes by detection of antibodies
by the agglutination, Enzyme Immune
Assay or any other principal.
3. The assay should have sensitivity of
99.5% or more and specificity of 98% or
more as per data from an identified
national reference laboratory.
4. The assay should have solid
phase/particles coated with synthetic
and/or recombination or both types of
antigens of HIV1 & HIV2.
5. Total procedure time should not be
more than 30 minutes.
6. The manufactures should ensure that
a. The test kit should be packed such
that there is a provision to conduct
single test at a time.
b. The assay components should
include HIV positive and negative
serum controls sufficient for conducting
20% of the tests (10% negative & 10%
positive controls); and
c. The pack size of HIV rapid test kits
should not be more than 50 tests per kit.
10
2
L/09
Bovine Albumin I.P. (10 ml Vial)
27
10ml Vial
1000
FORMAT FOR CHECK LIST in respect of
“E- TENDER FOR FEW DRUGS, LABORATORY KIT, CHEMICALS & REAGENTS
FOR THE YEAR 2014-15”
NIT No. ………………........
Date …………
Name of the Tenderer: - ___________________________________________
Full Address of the Tenderer: _______________________________________
__________________________________________________________________________________
______________________________________________
E-Mail : - ________________________________________________________
Contact person relating to vendor & Mob. No. :- _________________________
Tendering as: Manufacturer / Importer (Strike out which is ot applicable)
Status of Manufacture: State based S.S.I., State based P.S.U.,State based Others,
Others Outside W.B.) (Strike out which is ot applicable)
Average Annual Turn Over: Rs………………………………
Name of the proposed Distributor :
with Address & Contact No.
(For Outside Vendors only)
Pl mark 
Sn
Items
1
2
Application submitted in Annexure I
Annexure II ( Authorization letter of signatory from the
Company)
Annexure III ( Certification from Chartered Firm about
the monthly production capacity and % of sale in the
open market)
Annexure IV ( Copy of agreement between the
manufacturer and the Distributor as prescribed)
Annexure V (75% GRN Report).
Annexure VI (Draft Affidavit Proforma for Non
conviction)
Copy of Demand Draft of Rs 50,000/- in favour of Deputy
Director (Accounts), Central Medical Stores, Kolkata as
Earnest Money
Current registration as SSI as applicable
Copy of PAN Card of the authorised signatory :
Last 3 financial years’ returns of Income Tax i.e. for
2010-11, 2011-12& 2012-13
Last quarters of last 3 financial years’ returns of VAT for
2010-11, 2011-12& 2012-13
Last quarters of last 3 financial years’ returns of CST for
3
4
5
6
7
8
9
10
11
12
28
Yes
Yes
No
No
Yes
No
Yes
No
Yes
Yes
No
No
Yes
No
Yes
Yes
Yes
No
No
No
Yes
No
Yes
No
Page no.&
folder name
Remarks ( for
office use only)
13
14
15
16
17
18
19
20
22
23
2010-11, 2011-12& 2012-13
ESIC & EPF Registration Certificates
Service Tax, Professional Tax Regn. Certificate
Trade Licence/ Enlistment Certificate
Up-to-date Drug manufacturing Licence/Import Licence
& validity documents.
Up-to-date Drug endorsement copy/ Product
Enorsement Copy for each item quoted (marked with
CMS Cat. No.)
Certificate of market standing of the products to be
quoted from the State Drug Control authority for the last
three years i.e., 2010-11 , 2011 -12 & 2012-13 for drug
items.
Current GMP certification with Revised Schedule M
compliance certificate
Current GLP certificate
Current No-conviction certificate from the Director, Drug
control of the concerned state
Affidavit of non conviction affirmed before a First Class
Judicial Magistrate/Executive Magistrate or Notary
public (affidavit sworn after 01.12.2013), in Annexure-VI
Yes
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
No
Yes
No
Yes
Yes
No
No
Yes
No
Date:
Signature of the Participating Bidder
with Designation & Office seal
29
Annexure I
APPLICATION FORMAT
( To be furnished in the Company’s official letter pad with full address and contact no etc)
To
The Deputy Director of Health Services (E&S),
Central Medical Stores,
141, Acharya Jagadish Chandra Bose Road,
Kolkata – 700 014
Sub:
Ref: -
NIT for E-Tender for Chemicals & Reagents for the Government health facilities of West
Bengal for the year 2014-15
DDHS(E&S) N.I.T. No ………… ………………………………………………..dated ……………………..
Sir,
Having examined the pre-qualification & other documents published in the N.I.T, I /we hereby
submit all the necessary information and relevant documents for evaluation :
1.
That the application is made by me / us on behalf of…………………………………………………………
In the capacity……………………………………………..…duly authorized to submit the offer. The
authorization letter from the Company is attached in Annexure II.
2.
We accept the terms and conditions as laid down in the NIT mentioned above and declare that we
shall abide by it for throughout the tender period.
3.
We are offering rate for the following item /items with manufacturing capacity* and assured supply
to the Health & Family Welfare Department, Government of West Bengal:
Sn Catalogue No Drug name
Endorsed
in Manufacturing
Yearly
assured
Mfg.
License capacity per month
supply to the H&FW
No. / Imp.
Dept, GoWB in the
License No.
event of being
selected
* To be certified by a Chartered Firm in Annexure III
4.
We declare that we have achieved / have not achieved (strike out whichever is not applicable)
minimum 10% of sale of the production in the open market other than Health & Family Welfare
Dept, Government of West Bengal. The certification from Chartered Firm is attached as per
Annexure III.
5.
We declare that we have not been convicted under any provision of Drug and Cosmetics Act, 1940
and any other law in force from any competent authority or by any Court of law.
6.
a.
We propose that the order and bill should be raised in our name. We have appointed M/S
………………………………………………………………………………..
having
its
office
at
………………………………………………………………………………. (address, contact no and e mail address) as
C&F /CS Agent (strike out whichever is not applicable), Contact Person & No. being ………., as per
clause 9 of the NIT( This clause is applicable for out of state manufacturers)
OR
b.
We propose that order and bill should be raised in favour of our authorized distributor. For
that purpose, we have appointed M/S …………………………………………… having its office at
……………………………………………………….. (address with contact no and e mail address) as
authorized Distributor who will receive order and payment in his name on our behalf.
30
c.
The agreement between ourselves and the distributor/C&F& CS Agent other documents as
prescribed is attached in annexure IV( This clause is applicable for out of state
manufacturers).
7.
In the event of being selected, the Distributor Summary as asked for will be provided by us before
execution of agreement with the DDHS (E&S) **
(** This clause is valid for outside state manufacturer only. Local SSI/Firms/PSU/CPSU are not
allowed to engage Distributor. )
8.
We are the existing vendors in the CMS / We are not the existing vendor in the CMS (strike out
whichever is not applicable).
9.
Being an existing CMS approved drug vendor for the year 2013-14, necessary declaration of items
wise Good Received Note (GRN) over ordered value through Store Management Information system
(SMIS) is given in Annexure V (applicable for existing vendors only, others should strike out the
clause)
In the event of being selected, I will make the supply within the stipulated period excepting the
condition which is beyond our control.
10.
11.
We understand that:
(a) Tender Selection Committee/ H&FW Dept can amend the scope & value of the contract bid
under this project.
(b) Tender Selection Committee/ H&FW Dept reserves the right to reject any application without
assigning any reason.
Date :Signature of applicant including title
and capacity in which application is made.
Contact no :
Tele :
Mobile :
E Mail id.
31
Annexure II
Authorization letter in favour of the applicant (other than Managing Director/ Proprietor)
– from the competent authority.
FORMAT
( To be furnished in the Company’s official letter pad with full address and contact no, E mail address etc)
(TO WHOM IT MAY CONCERN)
This is to certify that Mr. ........................................................................................(Name), employee
of this Organisation as ............................................................ (Official Designation) is hereby authorised to
submit tender online , Vide NIT No.............................................................., Dated......................... on behalf
of the Organisation.
Signature of the
competent authority with Seal
.....................................................
(Signature of the Authorised Person)
Signature of Mr...................................................
..............................................is hereby attested.
Signature of the
competent authority with Seal
32
Annexure III
(Certificate from Chartered Firm)
This is to certify that having been examined the audited balance sheet/P/L accounts and other records that
M/S
…………………………………………………………………………………….…………….
having
its
office
at
…………………………………………………………. do have a monthly production capacity of the materials as given
hereunder :
Sn



Name of the drug for which applied
for
Monthly production capacity
It is certified that M/S …………………………………………………………………. have achieved average minimum
10% sale of the production in the open market other than Health & Family Welfare Dept,
Government of West Bengal for the drug or drugs for the year 2010-11, 2011-12 & 2012-13.
It is also certified that Annual Turnover of the firm for the Financial years 2010-11, 2011-12 & 201213 are Rs...............Cr., Rs..............Cr. & Rs...............Cr. respectively (as per P & L Balance sheet of the
firm, submitted)
Please note that Hard copies of the Annual Balance sheet and P/L account the year 2012-13, 201112 & 2010-11 will have to be submitted for verification after being L1.
Signature of the Chartered Firm with Registration No
Countersigned
Authorised signatory (tenderer)
33
Annexure IV
All out of the state manufacturers/ tenderers must have a distributor in this state. Copy of
agreement signed between the tenderer and the Distributor/C&F/Liaisoner as proof be submitted
here. (Before execution of agreement between tenderer and tendering authority).
34
Annexure V
Declaration from existing CMS approved drug vendors about supply of 75% of the ordered value in
Quantity as on 30.11.2014 made through STORE MANAGEMENT INFORMATION SYSTEM as on the
date of submission of tender
Sn
Catalogue No
Name of the Ordered value as
drug
per vendor portal
(including close
order) as stood
on
30th
November, 2014
GRN made as per
portal as stood on
…………(date
of
submission of bid)
% of GRN over
order value as on
submission
of
tender
1
2
3
etc
Signature of the authorized signatory
35
ANNEXURE VI
Draft Affidavit Proforma
I, Sri/Smt. ………………………………………………………………………
The Managing Director/Proprietor (etc.) of the Firm.
,……………………………………………………………… (Name of the firm)
At (address)…………………………………………………………………….…
P.O… …………………………………………………
P.S………………………………Dist……………………………………………
do hereby solemnly affirm and declare as follows:

That I have not ever been convicted of any offence making myself or my Company liable to be
disqualified to supply of Drugs, Laboratory Kits, Chemicals, & Reagents etc. to any Govt. or
Govt. undertaking Organization /Institution in the State of West Bengal or other State or States.

That no case is pending against me or against my firm in any criminal court of law to supply of
drugs, Chemicals, Lab. Chemicals & Reagents to the Govt. or Govt. undertaking Organization /
Institution in the State of West Bengal other State or States. ( If any case is pending, state the
details ).

That, I also declare that if any information subsequently found incorrect or false will it
automatically render the tender submitted by me cancelled and make me/my company liable for
penal/legal action as per law of the country.

That I do further affirm that the statements made by me in this tender are true to the best of my
knowledge and belief and all the documents attached are genuine.
Deponent(s).
36
IMPORTANT INFORMATION ABOUT ONLINE TENDERING
1.
SEARCHING THE TENDER
 After Login on wbtenders.gov.in with DSC Click on Search Active Tenders
 In keyword write WBHF or Tender memo. no. as reference no. on NIC website.
2.
DOWNLOADING THE TENDER DOCUMENTS
 After searching the particular tender you will find NIT & BOQ click on those to download and save
the documents.

Then fill the login Id and password which is written on top or your own login id and
password; the same page will appear again click on NIT & BOQ to download.

While downloading the BOQ please do not change the name of the BOQ.
3.
REGARDING MY DOCUMENTS
 First upload all the My Documents before starting the Bid Submission process.
 While starting the Bid submission process after the EMD payment you will find an option Do
you want to submit other Important documents.
 Here click on YES to submit the MY DOCUMENTS and then tick mark the check boxes to tag
those documents in that particular tender.

4.
This process will be carried out in each and every GROUP that you are participating.
BOQ
 While first opening the BOQ there is an option at top of the rows.
“Security warning Macros have been disabled” Click on options
 Select “Enable the content” then OK.
This will provide you the Total in Words
37

Sub:- Supply of Human

Decoking of DCU Heater tubes by Mechanical Pigging Method (DDT

quotation (computer) - the Tripura Medical College

Forestry Department Manuguru Ref.No.MNG/FTY/F.18/2014/150 Dt

E-TENDER NOTICE NO. /KMC/PWD/2014/May/02 . KMC/PWD/2014

B43481 - Luminex

A Subsidiary of Coal India Ltd. - BCCL | Bharat Coking Coal Limited

PDF Download - City of Nedlands

Tender Notice: Smart Mobile Phones 50 Nos. are required

Details - WBSEDCL